BriefTea
Every story in sixty words
Get the free app no ads · no paywallNews · 22 April 2026
A Phase 3 trial of Moderna's mRNA bird flu vaccine has launched in the UK and US, recruiting around 4,000 volunteers across 26 sites. The vaccine targets the H5N1 strain and uses the same technology as Covid jabs. Scientists aim to confirm it is safe and generates a strong immune response, guarding against a potential future pandemic.
Reported by BBC · How we write briefs
More briefs
HealthHealth Secretary Orders Plan to End Corridor Care for Children BusinessBarclays Spends Over £100m Cutting UK High Street Jobs WorldLecornu Blames Far-Left Groups for Organised Violence at French Protests TechnologyQualcomm says reports its new Snapdragon chip overheats are wrong GeneralNZ age-gap couples risk losing savings to rest-home costs SportsMatt Renshaw to bat at number five again for Australia in second Test Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.